CompletedPhase 2NCT02080637
Ambrisentan in Single Ventricle
Studying Dextrocardia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kevin Hill
- Principal Investigator
- Kevin Hill, MDDuke University
- Intervention
- Ambrisentan(drug)
- Enrollment
- 16 enrolled
- Eligibility
- All sexes
- Timeline
- 2015 – 2017
Study locations (1)
- Duke Universtiy Hospital, Durham, North Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02080637 on ClinicalTrials.gov